{
  "created_at": "2021-06-11T16:46:51.035Z",
  "title": "Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval",
  "url": "https://www.reuters.com/world/us/third-member-us-fda-advisory-panel-resigns-over-alzheimers-drug-approval-2021-06-10/",
  "author": "mrfusion",
  "points": 243,
  "num_comments": 121,
  "_tags": [
    "story",
    "author_mrfusion",
    "story_27472107",
    "front_page"
  ],
  "objectID": "27472107",
  "original_created_at": "2021-06-11T11:58:02.000Z",
  "localize": [
    {
      "locale": "ja",
      "title": "アルツハイマー型認知症治療薬の承認をめぐり、米国FDA諮問委員会の3人目のメンバーが辞任"
    },
    {
      "locale": "zh",
      "title": "美国FDA咨询小组的第三位成员因阿尔茨海默氏症药物的批准而辞职"
    },
    {
      "locale": "zh-Hant",
      "title": "美國FDA諮詢小組的第三位成員因阿爾茨海默氏症藥物的批准而辭職"
    }
  ],
  "source_updated_at": 1624009752562,
  "image": "https://www.reuters.com/resizer/uu9vHWBFQI0AxVM8XVKU8jd-j1I=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/7V2MAHYVNJIB3K475NQWJMWKZM.jpg"
}